PB2146: A PHASE 2, OPEN-LABEL STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) IN PREVIOUSLY UNTREATED UNFIT/FRAIL PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOM... by J. Westin, J. M. Burke, A. E. Chapman, T. Kilavuz, C. Xu, Y. Shmuely, J. Radford

Get full text

PB2109: REALMIND: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA STARTING SECOND/THIRD-LINE THERAPY AND NOT RECE... by C. R. Flowers, J. M. Burke, M. Vukcevic, S. Snodgrass, K. Saverno, M. A. A. Lumiqued

Get full text

Can soil phosphorus sorption saturation estimate future potential legacy phosphorus sources? by A. N. Sharpley, K. R. Brye, J. M. Burke, L. G. Berry, M. B. Daniels, P. Webb

Get full text

P1062: A REAL-WORLD EVALUATION OF THE ASSOCIATION BETWEEN ELEVATED BLOOD COUNTS AND THROMBOTIC EVENTS IN POLYCYTHEMIA VERA: AN ANALYSIS OF DATA FROM THE REVEAL STUDY by A. T. Gerds, R. Mesa, J. M. Burke, M. R. Grunwald, R. Scherber, J. Yu, J. Hamer-Maansson, S. T. Oh

Get full text

PB2113: FRONTMIND: A PHASE III, RANDOMIZED, DOUBLE-BLIND STUDY OF TAFASITAMAB + LENALIDOMIDE + R-CHOP VS R-CHOP ALONE FOR NEWLY DIAGNOSED HIGH-INTERMEDIATE AND HIGH-RISK DIFFUSE LA... by U. Vitolo, G. S. Nowakowski, J. M. Burke, C. P. Fox, M. Trneny, A. Chiappella, M. Waldron-Lynch, N. Hadar, A. Pachori, G. Lenz

Get full text

CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1 by J.F. Apgar, J.P. Tang, P. Singh, N. Balasubramanian, J.M. Burke, M.R. Hodges, M.A. Lasaro, L. Lin, B.L. Millard, K. Moore, L.S. Jun, S. Sobolov, A.K. Wilkins, X. Gao

Get full text

P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 ST... by H. Lee, I. W. Flinn, J. Melear, R. Ramchandren, J. Friedman, J. M. Burke, Y. Linhares, M. Raval, R. Chintapatla, T. A. Feldman, H. Yimer, M. Islas-Ohlmayer, A. Dean, V. Rana, M. D. Gandhi, J. Renshaw, A. L. Gillespie-Twardy, L. Ho, M. Puhlmann, W. Guo, C. A. Yasenchak

Get full text

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb tri... by M. Moehler, J. Heo, H.C. Lee, W.Y. Tak, Y. Chao, S.W. Paik, H.J. Yim, K.S. Byun, A. Baron, G. Ungerechts, D. Jonker, L. Ruo, M. Cho, A. Kaubisch, H. Wege, P. Merle, O. Ebert, F. Habersetzer, J.F. Blanc, Olivier Rosmorduc, R. Lencioni, R. Patt, A.M. Leen, F. Foerster, M. Homerin, N. Stojkowitz, M. Lusky, J.M. Limacher, M. Hennequi, N. Gaspar, B. McFadden, N. De Silva, D. Shen, A. Pelusio, D.H. Kirn, C.J. Breitbach, J.M. Burke

Get full text